Soleno Therapeutics, Inc. (SLNO): Dana dhuwit perusahaan

Simbol lan logo merek Soleno (SLNO)

Soleno Therapeutics (SLNO) is developing an exclusive treatment for Prader-Willi syndrome, aiming for monopoly dominance within the niche. The company maintains an impeccable scientific standing in the therapy of rare pathologies. On GURU.Markets, this linear cash accumulation chart demonstrates liquidity, where 0.25 serves as the current metric level. Strong investor confidence in the brand is bolstered by the success of clinical trials for its innovative developments.

Cadangan dhuwit perusahaan: Soleno (SLNO) kanggo 04.07.2022 - 30.05.2026

Ringkesan rincian data analitis Soleno Therapeutics Inc (SLNO)

- nilai saham lan prakiraan konsensus rega:
Ringkesan analitik perusahaan:SLNO Soleno Therapeutics Inc
Produk merek Soleno Therapeutics, Inc.

This indicator measures the volume of liquid assets on accounts, allowing for a real-time assessment of the company's financial stability and operational cushion. By analyzing the cash capital levels of Soleno Therapeutics (SLNO), an investor can determine the biotech startup's ability to fund the development of unique drugs for treating rare syndromes, which is critical for ensuring long-term dominance in a narrow niche.

Pesaing Soleno Therapeutics (SLNO)

Dana dhuwit perusahaan ascendispharma.com (ASND)|Dhuwit awis perusahaan madrigalpharma.com MDGL|Volume dana dhuwit perusahaan CORT (Corcept Therapeutics Inc.)|Sisa dhuwit perusahaan RYTM|AKRO - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Metsera Inc|MoonLake Immunotherapeutics AG (MLTX) - Dana dhuwit perusahaan|CRNX - Aset likuid perusahaan|NAMS (newamsterdampharma.com) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Amicus Pharma (FOLD)|Dhuwit awis perusahaan ETNB (89bio Corp)|Aset likuid perusahaan Agios Pharmaceuticals|Structure Pharma - Dhuwit awis perusahaan|MDXG: Dhuwit awis lan setara dhuwit awis perusahaan|RZLT: Dhuwit awis perusahaan|LXRX (Lexicon Pharma) - Dhuwit awis lan setara dhuwit awis perusahaan|MBX: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Altimmune, Inc. (ALT)|Dhuwit awis perusahaan AARD|Dana dhuwit perusahaan SGMT|Volume dana dhuwit perusahaan BIOA|Aset likuid perusahaan Biomea Fusion|Dana dhuwit perusahaan Quince Therapeutics QNCX|Volume dana dhuwit perusahaan Fractyl Health, Inc GUTS|VTVT: Dhuwit awis perusahaan|Cadangan dhuwit perusahaan Agape ATP|PLUR (Pluri) - Dhuwit awis perusahaan|SYBX - Aset likuid perusahaan|Dana dhuwit perusahaan Lipocine Corp|Volume dana dhuwit perusahaan matinasbiopharma.com|Dana dhuwit perusahaan Spruce Biosciences, Inc. (SPRB)|Gunggung dana dhuwit perusahaan GLTO|Carmell Corporation - Dhuwit awis perusahaan|LUMO - Dhuwit awis perusahaan|ONVO - Dana dhuwit perusahaan|Sisa dhuwit perusahaan RDUS (Radius Health)